In these studies, suppression of MYC has proven to induce tumor regression not only in those tumors considered MYC-driven[52,56-58], but also in those in which MYC is not the initiating oncogenic lesion[59,60], suggesting that MYC inhibition would represent an effective treatment for many cancer types. This evidence concerns the gene MYC and neoplasm.